Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China

Journal of Infection in Developing Countries

Volumn 8, Issue 8, 2014, Pages 1000-1005

  Xun, Meng ^a   Zhang, Yi ^b   Li, Bo Ling ^b   Wu, Min ^b   Zong, Yuan ^b   Yin, Yi Ming ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Clinical characteristics; Intensive care unit; Risk factors; Stenotrophomonas maltophilia

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; BRONCHOPNEUMONIA; CHINA; DRUG EFFECTS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHOPNEUMONIA; CHINA; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84906062803     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.4236     Document Type: Article

References (25)

1. Brooke JS (2012) Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25: 2-41.
2. Garazi M, Singer C, Tai J, Ginocchio CC (2012) Bloodstream infections caused by Stenotrophomonas maltophilia: a seven- year review. J Hosp Infect 81: 114-118.
3. Kaya M, Bestas R, Bacalan F, Bacaksiz F, Arslan EG, Kaplan MA (2012) Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. World J Gastroenterol 18: 3585-3589.
4. Khassawneh M, Hayajneh W (2010) Treatment of Stenotrophomonas neonatal urinary tract infection with instillation of ciprofloxacin. Pediatr Nephrol 25: 1377.
5. Zgair AK, Chhibber S (2010) Immunological and pathological aspects of respiratory tract infection with Stenotrophomonas maltophilia in BALB/c mice. J Microbiol Biotechnol 20: 1585-1591.
6. Bin AA, Zimmerman V, Al BB, Baddour LM, Tleyjeh IM (2009) Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature. Diagn Microbiol Infect Dis 63: 330-333.
7. Aydemir C, Aktas E, Eldes N, Kutsal E, Demirel F, Ege A (2008) Community-acquired infection due to Stenotrophomonas maltophilia: a rare cause of septic arthritis. Turk J Pediatr 50: 89-90.
8. Carrillo-Cordova JR, Amezcua-Guerra LM (2012) Autoimmunity as a possible predisposing factor for Stenotrophomonas maltophilia endocarditis. Arch Cardiol Mex 82: 204-207.
9. Huang CR, Chen SF, Tsai NW, Chang CC, Lu CH, Chuang YC, Chien CC, Chang WN (2013) Clinical characteristics of Stenotrophomonas maltophilia meningitis in adults: A high incidence in patients with a postneurosurgical state, long hospital staying and antibiotic use. Clin Neurol Neurosurg 115: 1709-1715.
10. Mahendradas P, Avadhani K, Anandula V, Shetty R (2012) Unilateral conjunctival ulcer due to Stenotrophomonas maltophilia infection. Indian J Ophthalmol 60: 134-136.
11. Nyc O, Matejkova J (2010) Stenotrophomonas maltophilia: Significant contemporary hospital pathogen - review. Folia Microbiol (Praha) 55: 286-294.
12. Yemisen M, Mete B, Tunali Y, Yentur E, Ozturk R (2008) A meningitis case due to Stenotrophomonas maltophilia and review of the literature. Int J Infect Dis 12: e125-127.
13. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibilitytesting: twentieth informational supplement, M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute.
14. Samonis G, Karageorgopoulos DE, Maraki S, Levis P, Dimopoulou D, Spernovasilis NA, Kofteridis DP, Falagas ME (2012) Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One 7: e37375.
15. Sader HS, Jones RN (2005) Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 25: 95-109.
16. Harthan AA, Heger ML (2013) Stenotrophomonas infection in a patient with glucose-6-phosphate dehydrogenase deficiency. J Pediatr Pharmacol Ther 18: 137-141.
17. Yezli S, Shibl AM, Livermore DM, Memish ZA (2012) Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia. J Chemother 24: 125-136.
18. Chang LL, Lin HH, Chang CY, Lu PL (2007) Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 59: 1038-1039.
19. Abbott IJ, Slavin MA, Turnidge JD, Thursky KA, Worth LJ (2011) Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther 9: 471-488.
20. Pathmanathan A, Waterer GW (2005) Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur Respir J 25: 911-914.
21. Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C, Pennisi C, Agodi A (2009) Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients. Int J Hyg Environ Health 212: 330-337.
22. Falagas ME, Kastoris AC, Vouloumanou EK, Dimopoulos G (2009) Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur J Clin Microbiol Infect Dis 28: 719-730.
23. Paez JI, Costa SF (2008) Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 70: 101-108.
24. Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G (2009) Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 4: 1103-1109.
25. Garazi M, Singer C, Tai J, Ginocchio CC (2012) Bloodstream infections caused by Stenotrophomonas maltophilia: a seven- year review. J Hosp Infect 81: 114-118.